Operating Cash Flow per Share: A measure of financial performance calculated as operating cash flow, expressed on a per share basis. Calculated as: Cash Flow from Operations / Weighted Average Shares Outstanding (Diluted)
Sagimet Biosciences Inc. (SGMT) had Operating Cash Flow per Share of $-0.26 for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-10.65M |
|
-- |
|
-- |
|
$11.71M |
|
$-11.71M |
|
$1.06M |
|
$-10.65M |
|
$-10.65M |
|
$-10.65M |
|
$-10.65M |
|
$-10.65M |
|
$-10.65M |
|
$-11.71M |
|
$-11.85M |
|
32.56M |
|
32.56M |
|
$-0.33 |
|
$-0.33 |
|
| Balance Sheet Financials | |
$107.72M |
|
-- |
|
$0.04M |
|
$107.75M |
|
$5.30M |
|
-- |
|
-- |
|
$5.30M |
|
$102.46M |
|
$102.46M |
|
$102.46M |
|
32.59M |
|
| Cash Flow Statement Financials | |
$-8.61M |
|
$10.22M |
|
-- |
|
$35.02M |
|
$36.63M |
|
$1.60M |
|
$1.84M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
20.34 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-8.61M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-10.39% |
|
-10.39% |
|
-9.88% |
|
-10.39% |
|
$3.14 |
|
$-0.26 |
|
|
Operating Cash Flow per Share |
$-0.26 |